Beyond Circulating Tumor Cell Enumeration: Cell-Based Liquid Biopsy to Assess Protein Biomarkers and Cancer Genomics Using the RareCyte® Platform

Frontiers in Pharmacology
March 3, 2022
Cited by 13


Related Papers